Skip to content
Search

Latest Stories

Medicine shortages in England: 20% of patients face delays in obtaining prescriptions

Medicine shortages in England: 20% of patients face delays in obtaining prescriptions

Many patients are forced to seek alternative services such as a GP or urgent care due to medicine shortages  

The growing issue of medicine shortages is posing significant challenges for both patients and pharmacy teams across the UK.

According to new data from the Office for National Statistics, 20 per cent of adults who used pharmacy prescription services in the last 28 days experienced delays in receiving their medications.


The survey, Experiences of NHS healthcare services in England, revealed that over 13 per cent of patients had to return to the same pharmacy at a later time to obtain their prescriptions.

Many patients were forced to visit multiple pharmacies or seek alternative services such as a GP or urgent care due to medicine shortages.

Pharmacy teams were added with extra burden to manage and resolve these issues.

Despite these challenges, 85 per cent of patients expressed satisfaction with pharmacy services, reflecting the dedication and value of pharmacists and pharmacy teams in the community.

James Davies, Director for England at the Royal Pharmaceutical Society (RPS), acknowledged that medicine shortages have grown substantially in recent years, placing a significant strain on both patients and pharmacy staff.

He said: "Patients rightly expect that when they are prescribed a medicine, they will receive it without undue delay.

“It’s thanks to the dedication and hard work of pharmacy teams that many of these problems are being addressed quickly, often by the next day.”

The survey also found that of those who faced difficulties obtaining their NHS prescriptions, 13.4 per cent had the issue resolved the same day, 28.5 per cent by the next day, 36.1 per cent within three to four days, 8.3 per cent after six days or later, and 13.6 per cent waited seven days or more for resolution.

Davies emphasised the urgent need for systemic reforms to tackle the root causes of supply chain issues.

"We urge manufacturers, wholesalers and the government to work together to improve the supply chain.”

Additionally, he advocated legal changes to allow pharmacists in England to make minor amendments to prescriptions.

“This would enable patients to access their medicines more quickly without needing to return to their GP,” he said.

“Changes are urgently needed to ensure patients receive their medications promptly and to reduce the strain on the whole of the NHS caused by medicine shortages,” he concluded.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less